Bessemer Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$792M Buy
860,704
+272,187
+46% +$276M 1.24% 11
2025
Q4
$632M Buy
588,517
+207,869
+55% +$199M 0.97% 14
2025
Q3
$290M Buy
380,648
+48,062
+14% +$35.8M 0.44% 45
2025
Q2
$259M Buy
332,586
+49,432
+17% +$38.4M 0.42% 52
2025
Q1
$234M Sell
283,154
-24,258
-8% -$20.2M 0.42% 58
2024
Q4
$237M Sell
307,412
-7,840
-2% -$6.49M 0.39% 58
2024
Q3
$279M Buy
315,252
+7,196
+2% +$6.47M 0.46% 44
2024
Q2
$279M Buy
308,056
+18,828
+7% +$15.1M 0.49% 43
2024
Q1
$225M Sell
289,228
-11,912
-4% -$8.48M 0.41% 59
2023
Q4
$176M Buy
301,140
+23,511
+8% +$13.7M 0.34% 78
2023
Q3
$149M Buy
277,629
+215,315
+346% +$111M 0.33% 86
2023
Q2
$29.2M Buy
62,314
+5,299
+9% +$2.22M 0.06% 202
2023
Q1
$19.6M Buy
57,015
+1,323
+2% +$446K 0.05% 205
2022
Q4
$20.4M Buy
55,692
+1,825
+3% +$647K 0.05% 203
2022
Q3
$17.4M Buy
53,867
+12,888
+31% +$4.08M 0.05% 206
2022
Q2
$13.3M Sell
40,979
-1,003
-2% -$301K 0.03% 214
2022
Q1
$12M Buy
41,982
+6,157
+17% +$1.58M 0.03% 208
2021
Q4
$9.9M Buy
35,825
+8,448
+31% +$2.14M 0.02% 209
2021
Q3
$6.33M Buy
27,377
+855
+3% +$211K 0.01% 235
2021
Q2
$6.09M Buy
26,522
+1,873
+8% +$376K 0.01% 244
2021
Q1
$4.61M Sell
24,649
-2,353
-9% -$460K 0.01% 259
2020
Q4
$4.56M Sell
27,002
-65,964
-71% -$9.85M 0.01% 250
2020
Q3
$13.8M Sell
92,966
-280,132
-75% -$43.4M 0.04% 190
2020
Q2
$61.3M Buy
373,098
+16,848
+5% +$2.59M 0.19% 122
2020
Q1
$49.4M Sell
356,250
-211,931
-37% -$29.1M 0.2% 126
2019
Q4
$74.7M Sell
568,181
-3,438
-0.6% -$399K 0.24% 119
2019
Q3
$63.9M Buy
571,619
+2,109
+0.4% +$235K 0.23% 125
2019
Q2
$63.1M Buy
569,510
+546,307
+2,354% +$64.3M 0.21% 137
2019
Q1
$3.01M Sell
23,203
-1,450
-6% -$176K 0.01% 368
2018
Q4
$2.85M Buy
24,653
+393
+2% +$43.9K 0.01% 290
2018
Q3
$2.6M Sell
24,260
-1,393
-5% -$139K 0.01% 334
2018
Q2
$2.19M Sell
25,653
-9,593
-27% -$788K 0.01% 387
2018
Q1
$2.73M Sell
35,246
-3,132,885
-99% -$252M 0.01% 349
2017
Q4
$268M Sell
3,168,131
-8,975
-0.3% -$764K 1.04% 20
2017
Q3
$272M Buy
3,177,106
+1,247
+0% +$102K 1.08% 14
2017
Q2
$261M Buy
3,175,859
+14,607
+0.5% +$1.19M 1.05% 20
2017
Q1
$266M Buy
3,161,252
+3,113,923
+6,579% +$249M 1.11% 15
2016
Q4
$3.48M Buy
47,329
+3,459
+8% +$258K 0.02% 375
2016
Q3
$3.52M Sell
43,870
-14,330
-25% -$1.15M 0.02% 342
2016
Q2
$4.58M Sell
58,200
-10,878
-16% -$819K 0.03% 314
2016
Q1
$4.97M Buy
69,078
+4,159
+6% +$315K 0.03% 290
2015
Q4
$5.47M Buy
64,919
+13,283
+26% +$1.1M 0.03% 242
2015
Q3
$4.32M Buy
51,636
+1,838
+4% +$155K 0.02% 277
2015
Q2
$4.16M Buy
49,798
+1,207
+2% +$92K 0.02% 301
2015
Q1
$3.53M Buy
48,591
+821
+2% +$58.5K 0.02% 307
2014
Q4
$3.29M Buy
47,770
+583
+1% +$39.4K 0.02% 298
2014
Q3
$3.06M Buy
47,187
+1,740
+4% +$110K 0.02% 306
2014
Q2
$2.83M Sell
45,447
-546
-1% -$32.6K 0.02% 295
2014
Q1
$2.71M Sell
45,993
-1,668
-3% -$93.1K 0.02% 278
2013
Q4
$2.43M Buy
47,661
+338
+0.7% +$16.9K 0.02% 313
2013
Q3
$2.38M Buy
47,323
+946
+2% +$49.5K 0.02% 277
2013
Q2
$2.28M Buy
+46,377
New +$2.52M 0.02% 270

Other funds holding LLY

Bessemer Group's LLY Position: Q1 2026 in Review

Bessemer Group increased its Eli Lilly (LLY) stake by 46% in Q1 2026, buying an estimated $276M and bringing the position to 860,704 shares worth $792M. The position accounts for 1.24% of the portfolio, ranked #11.

Bessemer Group first reported a position in LLY in Q2 2013 and has held it in 52 quarters since. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Bessemer Group held 860,704 shares of Eli Lilly worth $792M as of Q1 2026.
  • Bessemer Group bought 272,187 Eli Lilly shares in Q1 2026, an estimated $276M.
  • Eli Lilly made up 1.24% of Bessemer Group's portfolio in Q1 2026, its #11 holding.
  • Bessemer Group first reported a position in Eli Lilly in Q2 2013 and has held it in 52 quarters since.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Bessemer Group's 13F filing for Q1 2026, filed 6 May 2026.